Q3 2025 · 13F-HR
Atalan Capital Partners, LPholdings as filed
Filed 2025-11-14 · accession 0001662906-25-000006
$1.43B
Reported value
10
Positions
2025-09-30
Period end
The Brief · Atalan Capital Partners, LP · Q3 2025
AI · grounded in 13F
Atalan Capital Partners, LP closed its position in Thermo Fisher Scientific Inc TMO, reducing its holdings by $44.6M. The fund increased its stake in SEAGATE TECHNOLOGY HLDNGS PL by 49.32% and HealthEquity Inc HQY by 30.23%. Additionally, the fund trimmed its position in Talen Energy Corp TLN by 37.45%.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 032095101 | APH | AMPHENOL CORP NEW | $184.1M | 12.9% | 1,488,000 | Common | SOLE |
| G96629103 | WTW | WILLIS TOWERS WATSON PLC LTD | $178.0M | 12.4% | 515,300 | Common | SOLE |
| G7997R103 | STX | SEAGATE TECHNOLOGY HLDNGS PL | $176.2M | 12.3% | 746,600 | Common | SOLE |
| 78409V104 | SPGI | S&P GLOBAL INC | $150.5M | 10.5% | 309,200 | Common | SOLE |
| 57636Q104 | MA | MASTERCARD INCORPORATED | $137.8M | 9.62% | 242,200 | Common | SOLE |
| 87422Q109 | TLN | TALEN ENERGY CORP | $135.7M | 9.47% | 319,000 | Common | SOLE |
| 958102105 | WDC | WESTERN DIGITAL CORP | $133.4M | 9.31% | 1,110,788 | Common | SOLE |
| 912008109 | USFD | US FOODS HLDG CORP | $128.2M | 8.95% | 1,673,000 | Common | SOLE |
| 893641100 | TDG | TRANSDIGM GROUP INC | $122.2M | 8.53% | 92,750 | Common | SOLE |
| 42226A107 | HQY | HEALTHEQUITY INC | $86.4M | 6.03% | 911,600 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.